VNDRIQ — Vendor Comparison
ScreenPoint Medical vs CARPL.ai
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
ScreenPoint Medical
Medical Imaging AI
Verification pending
CARPL.ai
Medical Imaging AI
Last verified: August 31, 2026
VNDRIQ Scores
63
Overall
82
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
Quarterly
Quarterly
Recommended Use
Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).
Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.
Restrictions
Must be used as a concurrent or second reader by qualified radiologists; not intended for autonomous diagnostic action.
Only integrates third-party AI models that have received their own independent FDA clearance.
Executive Summary
ScreenPoint Medical
Medical Imaging AI
ScreenPoint Medical is classified as Approved with a BAA status of Available for clinical deployments in the United States.. PHI exposure is rated High and AI training risk is Medium. Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).
43
Privacy
85
Governance
69
Healthcare
55
AI Risk
CARPL.ai
Medical Imaging AI
CARPL.ai is classified as Approved with a BAA status of Available upon request. PHI exposure is rated Medium and AI training risk is Low. Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.
68
Privacy
85
Governance
83
Healthcare
90
AI Risk
Recommended For
ScreenPoint Medical
Clinical decision support for radiologists during the interpretation of screening mammograms and digital breast tomosynthesis (3D mammography).
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
CARPL.ai
Orchestration and deployment of FDA-cleared third-party radiology AI applications within clinical workflows.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
Governance Considerations
ScreenPoint Medical
PHI exposure is elevated. Review data flow documentation.
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Must be used as a concurrent or second reader by qualified radiologists; not intended for autonomous diagnostic action.
CARPL.ai
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Only integrates third-party AI models that have received their own independent FDA clearance.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.